NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CSBR

Champions Oncology Inc

Jul 03 • 01:30PM ET

7.68

Dollar change -0.09
Percentage change -1.16	%

Healthcare • Biotechnology • USA • NASD

Peers: INCY BPMC FATE ZLAB KURA PBYI XENE ONCT MEIP IKT

| Held by: VTI VXF IWC DFAC DCOR DFSU

Scroll to Statements

Index	-	P/E	17.06	EPS (ttm)	0.45	Insider Own	55.76%	Shs Outstand	13.71M	Perf Week	6.37%
Market Cap	106.19M	Forward P/E	34.91	EPS next Y	0.22	Insider Trans	0.00%	Shs Float	6.12M	Perf Month	19.44%
Enterprise Value	109.69M	PEG	-	EPS next Q	-0.20	Inst Own	19.27%	Short Float	1.57%	Perf Quarter	-13.22%
Income	6.43M	P/S	1.81	EPS this Y	165.22%	Inst Trans	12.41%	Short Ratio	2.70	Perf Half Y	-10.90%
Sales	58.59M	P/B	19.25	EPS next Y	-26.67%	ROA	22.39%	Short Interest	0.10M	Perf YTD	-10.39%
Book/sh	0.40	P/C	33.18	EPS next 5Y	-	ROE	376.84%	52W High	11.99 -35.95%	Perf Year	54.84%
Cash/sh	0.23	P/FCF	-	EPS past 3/5Y	- -	ROIC	60.77%	52W Low	3.60 113.33%	Perf 3Y	4.82%
Dividend Est.	-	EV/EBITDA	12.58	Sales past 3/5Y	6.91% 13.13%	Gross Margin	51.58%	Volatility	8.34% 9.15%	Perf 5Y	-19.58%
Dividend TTM	-	EV/Sales	1.87	EPS Y/Y TTM	165.43%	Oper. Margin	11.48%	ATR (14)	0.61	Perf 10Y	-7.25%
Dividend Ex-Date	-	Quick Ratio	0.99	Sales Y/Y TTM	19.03%	Profit Margin	10.97%	RSI (14)	55.11	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.99	EPS Q/Q	268.14%	SMA20	3.40%	Beta	0.47	Target Price	12.00
Payout	-	Debt/Eq	1.22	Sales Q/Q	41.77%	SMA50	13.12%	Rel Volume	0.33	Prev Close	7.77
Employees	210	LT Debt/Eq	0.93	Earnings	Mar 11 BMO	SMA200	6.51%	Avg Volume	35.48K	Price	7.68
IPO	Jun 15, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	3700.00% 32.09%	Trades		Volume	11,533	Change	-1.16%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-12-24	Upgrade	Craig Hallum	Hold → Buy	$6
Nov-18-19	Initiated	The Benchmark Company	Speculative Buy

Apr-28-25 09:45AM	Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House (ACCESSWIRE) -7.47%
Apr-24-25 08:00AM	Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine (ACCESSWIRE)
Apr-21-25 04:20PM	Champions Oncology Inc (CSBR) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Mar-11-25 03:55PM	Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million (ACCESSWIRE) +10.00%
Mar-06-25 04:00PM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 (ACCESSWIRE)
09:00AM	Loading…
Feb-18-25 09:00AM	Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting (ACCESSWIRE)
Feb-14-25 03:47PM	Schrodinger Stock Scores IBD Rating Upgrade (Investor's Business Daily)
Jan-09-25 08:30AM	Champions Oncology integrates Cytek Aurora flow cytometers (TipRanks)
Jan-08-25 08:00AM	Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership (ACCESSWIRE) -8.00%
Dec-11-24 04:00PM	Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million (ACCESSWIRE) +12.09% -11.64%
Dec-05-24 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 (ACCESSWIRE) +6.22%
Oct-16-24 10:55AM	Champions Oncology Announces Agreement with Weill Cornell Medicine (ACCESSWIRE)
Oct-09-24 07:00PM	Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:05PM	Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Sep-12-24 08:03AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript (Insider Monkey) +9.58%
04:00PM	Loading…
Sep-11-24 04:00PM	Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million (ACCESSWIRE)
Sep-09-24 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 (ACCESSWIRE) -6.62%
Jul-18-24 09:53PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
04:00PM	Champions Oncology Reports Quarterly Revenue of $14.0 Million (ACCESSWIRE)
Jul-11-24 04:05PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 (ACCESSWIRE)
Jun-04-24 09:00AM	Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development (ACCESSWIRE)
Mar-19-24 08:28AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Mar-12-24 04:30PM	Champions Oncology Reports Quarterly Revenue of $12.0 Million (ACCESSWIRE)
Mar-07-24 09:00AM	Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation (ACCESSWIRE)
Mar-06-24 04:35PM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 (ACCESSWIRE)
Dec-14-23 08:22AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript (Insider Monkey)
Dec-12-23 09:54PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.49% +5.42%
04:00PM	Champions Oncology Reports Quarterly Revenue of $11.6 Million (ACCESSWIRE)
Dec-04-23 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023 (ACCESSWIRE)
Nov-02-23 08:30AM	Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification (ACCESSWIRE)
08:30AM	Loading…
Oct-17-23 08:30AM	Champions Oncology Announces the Addition of Brady Davis as President (ACCESSWIRE)
Sep-13-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.6 Million (ACCESSWIRE) -16.29%
Sep-11-23 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023 (ACCESSWIRE)
Aug-22-23 08:30AM	Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023 (ACCESSWIRE)
Aug-01-23 08:45AM	Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies (ACCESSWIRE)
Jul-24-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $13.1 Million (ACCESSWIRE) -8.03%
Jul-20-23 04:00PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 (ACCESSWIRE)
Apr-17-23 08:30AM	Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development (ACCESSWIRE) +8.54%
Apr-05-23 09:50AM	Champions Oncology Announces $5M Stock Repurchase Program (ACCESSWIRE) +5.26%
Mar-15-23 03:50PM	Champions Oncology Reports Quarterly Revenue of $12.8 Million (ACCESSWIRE)
Mar-13-23 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023 (ACCESSWIRE)
Dec-16-22 08:48AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2023 Earnings Call Transcript (Insider Monkey) -10.91%
Dec-13-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $14.3 Million (ACCESSWIRE) +5.21% -31.04%
Dec-09-22 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 (ACCESSWIRE)
Sep-08-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $13.7 Million (ACCESSWIRE)
Sep-06-22 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022 (ACCESSWIRE) -5.38%
Aug-15-22 08:08AM	What Type Of Shareholders Make Up Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Registry? (Simply Wall St.)
Jul-23-22 09:57AM	We Ran A Stock Scan For Earnings Growth And Champions Oncology (NASDAQ:CSBR) Passed With Ease (Simply Wall St.)
Jul-21-22 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.9 Million (ACCESSWIRE) +8.12%
Jul-14-22 04:00PM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 (ACCESSWIRE)
Jun-13-22 06:30AM	Investors in Champions Oncology (NASDAQ:CSBR) have made a impressive return of 197% over the past five years (Simply Wall St.)
May-31-22 08:30AM	Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics (ACCESSWIRE)
May-03-22 08:30AM	Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo (ACCESSWIRE)
May-02-22 01:16PM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? (Simply Wall St.)
Mar-15-22 04:45PM	Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million (ACCESSWIRE) +8.17%
Mar-11-22 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022 (ACCESSWIRE)
Mar-07-22 01:10PM	Do Institutions Own Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.)
Feb-15-22 08:30AM	Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors (ACCESSWIRE) +6.47%
Jan-20-22 08:30AM	Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates (ACCESSWIRE)
Jan-04-22 08:30AM	Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs (ACCESSWIRE)
05:07AM	Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their impressive 149% return over the last five years (Simply Wall St.)
Dec-13-21 04:20PM	Champions Oncology Reports Record Quarterly Revenue of $11.8 Million (ACCESSWIRE)
Dec-06-21 09:20AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021 (ACCESSWIRE)
Nov-05-21 08:24AM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? (Simply Wall St.)
Oct-20-21 10:25AM	Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus (ACCESSWIRE)
Sep-13-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $11.3 Million (ACCESSWIRE)
Sep-06-21 03:00PM	Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect (Zacks)
07:09AM	What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares? (Simply Wall St.)
Sep-02-21 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 (ACCESSWIRE) +5.49%
Jul-26-21 08:30AM	Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development (ACCESSWIRE)
Jul-22-21 08:00AM	Champions Oncology Reports Quarterly Revenue of $10.6 Million (ACCESSWIRE)
Jul-14-21 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 (ACCESSWIRE)
Jul-08-21 03:06AM	The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted (Simply Wall St.)
Jun-15-21 09:00AM	Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions (ACCESSWIRE)
Apr-29-21 03:31AM	Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation (Simply Wall St.) +5.34%
Apr-16-21 12:00PM	Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-16-21 10:52AM	Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength? (Zacks)
Mar-15-21 02:13AM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.) +15.31%
Mar-11-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.8 Million (ACCESSWIRE) +8.09%
02:30PM	Champions Oncology, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-05-21 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 (ACCESSWIRE)
Mar-04-21 12:30PM	Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-21 09:00AM	Champions Oncology Announces Addition to Board of Directors (ACCESSWIRE)
Jan-29-21 12:24AM	Can You Imagine How Jubilant Champions Oncology's (NASDAQ:CSBR) Shareholders Feel About Its 220% Share Price Gain? (Simply Wall St.)
Jan-19-21 09:00AM	Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics (ACCESSWIRE)
Jan-05-21 08:30AM	Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics (ACCESSWIRE)
Dec-15-20 12:22AM	Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 25%? (Simply Wall St.)
Dec-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.1 Million (ACCESSWIRE)
Dec-07-20 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 (ACCESSWIRE) +7.07%
Nov-16-20 04:40PM	Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program (ACCESSWIRE) +14.94%
Nov-11-20 09:00AM	Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform (ACCESSWIRE)
Oct-31-20 10:08AM	Should You Investigate Champions Oncology, Inc. (NASDAQ:CSBR) At US$8.78? (Simply Wall St.)
Sep-16-20 07:27AM	Champions Oncology, Inc. Just Beat Revenue Estimates By 11% (Simply Wall St.)
Sep-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $9.5 Million (ACCESSWIRE) +9.23%
Sep-08-20 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020 (ACCESSWIRE) -9.35%
Jul-30-20 07:21AM	Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts (Simply Wall St.)
Jul-27-20 04:01PM	Champions Oncology Reports Quarterly Revenue of $8.8 Million (ACCESSWIRE)
Jul-22-20 08:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020 (ACCESSWIRE) +6.75%
Jul-15-20 03:55PM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.)
Jun-17-20 09:37AM	The Truth About Market Timing - June 17, 2020 (Zacks)

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ACKERMAN JOEL	Director	Oct 31 '24	Option Exercise	2.63	105,137	276,289	962,134	Nov 01 09:04 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CSBR

Champions Oncology Inc

Upgrade your FINVIZ experience